Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the percent change in fasting serum triglyceride (TG) levels and to investigate safety by assessing the incidence of adverse events (AEs) and adverse d...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Atheroscler Thromb
Huvudupphovsmän: Arai, Hidenori, Yamashita, Shizuya, Yokote, Koutaro, Araki, Eiichi, Suganami, Hideki, Ishibashi, Shun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Japan Atherosclerosis Society 2018
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005227/
https://ncbi.nlm.nih.gov/pubmed/29628483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.44412
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk